SAN FRANCISCO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- PACS Group, Inc. (NYSE: PACS) and certain of its key executives have been named as defendants in a securities class action brought on behalf of PACS investors alleging violations of the U.S. securities laws. Hagens Berman has begun an investigation into the matter and urges investors in PACS Group who purchased shares pursuant to PACS’ April 2024 IPO or on the post-IPO open market and suffered substantial losses to submit your losses now. Class Period: Apr. 1 ...

LOS ANGELES, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PACS Group, Inc. ("PACS Group" or the "Company") (NYSE: PACS) investors of a class action representing investors that bought securities between April 11, 2024 and November 05, 2024, inclusive (the "Class Period"). PACS Group investors have until January 13, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their lega ...

PHILADELPHIA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors who purchased stock in PACS Group, Inc. (NYSE: PACS), from April 11, 2024 through and including November 5, 2024 (the “Class Period”).  WHAT’S THIS ABOUT?On November 4, 2024, Hindenburg Research published a research report about PACS alleging, among other things, that the company has been “systematically scamming taxpayers.” According to Hindenbu ...

BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Block & Leviton announces that a securities fraud lawsuit has been filed against PACS Group, Inc. (NYSE: PACS). Investors who have lost money in their PACS Group investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://www.blockleviton.com/cases/pacs. What is this all about? A lawsuit has been filed against PACS Group, Inc., alleging that the Defendants failed to disclose to investors: (1) that the C ...

诉讼背景 - 集体诉讼针对PACS Group公司 指控违反1933年证券法和1934年证券交易法 [1] - 诉讼代表2024年4月11日至11月5日期间购买证券及通过IPO购买普通股的投资者 [1] - 主要被告包括公司高管 董事及IPO承销商 [1] 公司业务与IPO详情 - 公司通过子公司在美国经营专业护理机构和辅助生活设施 [3] - 2024年4月11日进行IPO 发行2140万股普通股 发行价每股21美元 [3] - 公司通过IPO获得净收益约4.5亿美元 [3] 指控内容 - 公司被指控通过虚假医疗保险索赔驱动收入 2020-2023年间该操作贡献超过100%的经营和净收入 [4] - 涉嫌向医疗保险申报数千项不必要的呼吸和感官整合治疗 [4] - 存在伪造执照和人员配置相关文件的行为 [4] 股价影响事件 - 2024年11月4日Hindenburg研究报告发布后 公司股价单日下跌超过27% [5] - 2024年11月6日公司推迟第三季度财报发布并披露收到联邦政府民事调查要求 股价再度下跌38.7% [6] - 两项事件累计造成股价大幅下跌 [5][6] 法律程序 - 符合资格的投资者可在2025年1月13日前申请担任首席原告 [1][7] - 首席原告需在拟议类别中具有最大财务利益 [7] - 参与诉讼不代表必须担任首席原告身份 [7]

关于PACS集团诉讼相关 - 2024年11月14日Bleichmar Fonti & Auld LLP宣布对PACS集团及其部分高管提起诉讼 涉嫌违反联邦证券法 鼓励投资者通过https://www.bfalaw.com/cases - investigations/pacs - group - inc获取更多信息 [1] - 投资者可在2025年1月13日前请求法院被任命领导此案 诉讼依据1933年证券法第11和15条以及1934年证券交易法第10(b)和20(a)条代表PACS证券投资者提出索赔 案件在纽约南区美国地方法院待审 [2] - 投诉称PACS是美国最大的专业护理机构运营商之一 公司向股东表示有成功的扭亏为盈策略 但实际上涉嫌通过非法获取数千患者的医疗保险福利来实现扭亏为盈 [3] - 2024年11月4日Hindenburg Research发布报告称PACS滥用新冠时期的豁免权 不当获取数千患者的医疗保险福利 估计该计划在2020 - 2023年推动了PACS超过100%的营业和净收入 使其在2024年初以合法增长和盈利的假象进行IPO [4] - 2024年11月6日PACS宣布推迟其第三季度财报 称收到联邦政府关于公司报销和转诊做法的民事调查要求 可能与第三方报告有关 [4] - PACS股票价格显著下跌 11月4日股价下跌27.8% 从11月1日的每股42.94美元跌至11月4日的每股31.01美元 11月6日股价下跌38.8% 从11月5日的每股29.54美元跌至11月6日的每股18.09美元 [4] Bleichmar Fonti & Auld LLP相关 - 这是一家领先的国际律师事务所 代表证券集体诉讼和股东诉讼中的原告 2023年被ISS SCAS评为前5大原告律师事务所 其律师被Law360评为原告律师界的巨头 被Thompson Reuters评为超级律师 [6] - 该公司近期成功从特斯拉公司董事会追回超过9亿美元价值（有待法院批准） 从梯瓦制药工业有限公司追回4.2亿美元 [7]

NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into PACS Group, Inc. (NYSE: PACS) for potential violations of the federal securities laws. If you invested in PACS, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/pacs-group-inc. Why Did PACS’s Stock Drop? PACS is one of the largest operators of skilled nursing facilities in the United States. PACS has repeatedly represen ...

SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether PACS Group, Inc. (NYSE: PACS) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. On November 4, 2024, Hindenburg Research issued a report questioning PACS claims to have discovered a winning ‘turnaround’ formula for transforming poorly performing skilled nursing facilities into “cash ...

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of PACS Group, Inc. (NYSE: PACS) resulting from allegations that PACS Group may have issued materially misleading business information to the investing public. So What: If you purchased PACS Group securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrang ...

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into PACS Group, Inc. (NYSE: PACS) for potential violations of the federal securities laws. If you invested in PACS, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/pacs-group-inc. Why Did PACS’s Stock Drop? PACS is one of the largest operators of skilled nursing facilities in the United States. PACS has repeatedly represen ...